MAIA Biotechnology CEO Details Anticipated Clinical Milestones for Novel Cancer Immunotherapy in 2025 Letter to Shareholders ...

AI systems already work their magic in many areas of biomedical science, helping to solve protein structure, discover hidden ...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...

A field known as synthetic biology has become one of the most highly anticipated in science. Its outputs range from golden ...

PASADENA, Calif, March 27, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ("LIXTE” or the "Company”) (Nasdaq: ...

“The potential risks from eating GM foods have not been fully investigated…. There is no scientific consensus on the safety ...

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

A Durham biotechnology company has seen its stock price plummet over the past few days amid a stock offering and a media ...

Immunic, Inc. to Participate in Scientific and Industry Conferences in April ...

Researchers have developed new AI models that can vastly improve accuracy and discovery within protein science. Potentially, the models will assist the medical sciences in overcoming present ...

Viral contamination in cell cultures poses significant challenges, particularly due to the necessity for complex detection ...

Pre-Clinical Study in Collaboration with Netherlands Cancer Institute is in addition to LIXTE’s Ongoing Clinical Trials for Ovarian and ...